loadpatents
Patent applications and USPTO patent grants for Jiao; XianYun.The latest application filed is for "piperidinone derivatives as mdm2 inhibitors for the treatment of cancer".
Patent | Date |
---|---|
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20220169611 - Bartberger; Michael D. ;   et al. | 2022-06-02 |
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20210179560 - Bartberger; Michael D. ;   et al. | 2021-06-17 |
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20190062276 - Bartberger; Michael D. ;   et al. | 2019-02-28 |
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20170144971 - BARTBERGER; Michael D. ;   et al. | 2017-05-25 |
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer Grant 9,593,129 - Bartberger , et al. March 14, 2 | 2017-03-14 |
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20160137667 - BARTBERGER; Michael D. ;   et al. | 2016-05-19 |
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer Grant 9,296,736 - Bartberger , et al. March 29, 2 | 2016-03-29 |
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer App 20140315895 - Bartberger; Michael D. ;   et al. | 2014-10-23 |
Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions Grant 8,785,468 - Du , et al. July 22, 2 | 2014-07-22 |
Spirocyclic GPR40 modulators Grant 8,748,462 - Brown , et al. June 10, 2 | 2014-06-10 |
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer App 20140011796 - BARTBERGER; Michael David ;   et al. | 2014-01-09 |
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer App 20110319378 - BARTBERGER; Michael David ;   et al. | 2011-12-29 |
Heterocyclic GPR40 modulators Grant 8,003,648 - Beck , et al. August 23, 2 | 2011-08-23 |
Spirocyclic Gpr40 Modulators App 20110190330 - Brown; Sean P. ;   et al. | 2011-08-04 |
Heterocyclic GPR40 modulators Grant 7,714,008 - Beck , et al. May 11, 2 | 2010-05-11 |
Furanopyridine derivatives and methods of use Grant 7,674,907 - Nunes , et al. March 9, 2 | 2010-03-09 |
Pyrrolo[2,3-d]pyrimidines that modulate ACK1 activity Grant 7,358,250 - Farthing , et al. April 15, 2 | 2008-04-15 |
Antiinflammation agents Grant 7,199,119 - Burkitt , et al. April 3, 2 | 2007-04-03 |
Pyrrolo[2,3-d]pyrimidines that modulate ACK1 activity App 20060040965 - Farthing; Christopher N. ;   et al. | 2006-02-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.